<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26590154</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0973-7693</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>Indian journal of pediatrics</Title><ISOAbbreviation>Indian J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Association Between Angiopoietin-2 and Enterovirus 71 Induced Pulmonary Edema.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>396</EndPage><MedlinePgn>391-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12098-015-1920-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To characterize pulmonary edema (PE) fluid induced by enterovirus 71 (EV71) infection, elucidate the relationship between angiopoietin-2 (Ang-2) and PE, and explore the pathogenesis of PE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Clinical data were collected from critical infants with EV71 infection. The infants were grouped into PE, non-PE, and control groups. The control group included infants in the preoperative period of elective inguinal hernia surgery. Biochemical changes in PE fluid were evaluated, and Ang-2 levels in serum and PE fluid were measured. Human pulmonary microvascular endothelial cells (HPMECs) were incubated with serum from the control and PE groups and human recombinant Ang-2 or serum from the PE group and human recombinant Ang-1, and changes in the intercellular junctions were recorded via immunofluorescence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 161 infants with critical EV71 infection admitted to the hospital, 39 had PE. PE fluid was collected from 18 of these infants. The PE fluid-to-serum (P/S) ratio of total protein was 0.9&#x2009;&#xb1;&#x2009;0.2, and all P/S ratios of albumin were 1.0&#x2009;&#xb1;&#x2009;0.3. The Ang-2 level was higher in the non-PE group (333.2&#x2009;&#xb1;&#x2009;79.7&#xa0;pg/ml) than in the control group (199.9&#x2009;&#xb1;&#x2009;26.7&#xa0;pg/ml), although without statistical significance (P&#x2009;=&#x2009;0.115). The Ang-2 level in the PE group (2819.2&#x2009;&#xb1;&#x2009;908.7&#xa0;pg/ml) was higher than those in both the non-PE and the control groups (both, P&#x2009;&lt;&#x2009;0.001). Serum samples from the PE group had damaged cell junctions of confluent HPMEC monolayers that were reversed by Ang-1.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The PE fluid of infants with EV71-induced PE was protein-rich, and elevated Ang-2 expression was associated with PE. The mechanism through which PE develops may be related to Ang-2-induced cell junction damage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Zhijiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yongfu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Fuju</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaozhi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Affiliated Hospital of Binzhou Medical University, Binzhou, Shandong Province, 256600, China. hxicuwxz@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Pediatr</MedlineTA><NlmUniqueID>0417442</NlmUniqueID><ISSNLinking>0019-5456</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042683">Angiopoietin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042702">Angiopoietin-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D042683" MajorTopicYN="N">Angiopoietin-1</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042702" MajorTopicYN="Y">Angiopoietin-2</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002199" MajorTopicYN="Y">Capillary Permeability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018495" MajorTopicYN="Y">Fluid Shifts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011654" MajorTopicYN="Y">Pulmonary Edema</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013396" MajorTopicYN="N">Suction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiopoietin-2</Keyword><Keyword MajorTopicYN="N">Endothelial intercellular junctions</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Pulmonary edema fluid</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26590154</ArticleId><ArticleId IdType="pmc">PMC7101583</ArticleId><ArticleId IdType="doi">10.1007/s12098-015-1920-2</ArticleId><ArticleId IdType="pii">10.1007/s12098-015-1920-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen KT, Chang HL, Wang ST, Cheng YT, Yang JY. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan. Pediatrics. 2007;120:e244&#x2013;52. doi: 10.1542/peds.2006-3331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2006-3331</ArticleId><ArticleId IdType="pubmed">17671037</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand foot and mouth disease. Lancet. 1999;354:1682&#x2013;6. doi: 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JM, Wang JN, Tsai YC, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics. 2002;109:E26. doi: 10.1542/peds.109.2.e26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.2.e26</ArticleId><ArticleId IdType="pubmed">11826236</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res. 1997;81:567&#x2013;74. doi: 10.1161/01.RES.81.4.567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.81.4.567</ArticleId><ArticleId IdType="pubmed">9314838</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarter SD, Mei SH, Lai PF, et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med. 2007;175:1014&#x2013;26. doi: 10.1164/rccm.200609-1370OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200609-1370OC</ArticleId><ArticleId IdType="pubmed">17322110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mofarrahi M, Nouh T, Qureshi S, Guillot L, Mayaki D, Hussain SN. Regulation of angiopoietin expression by bacterial lipopolysaccharide. Am J Physiol Lung Cell Mol Physiol. 2008;294:L955&#x2013;63. doi: 10.1152/ajplung.00449.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00449.2007</ArticleId><ArticleId IdType="pubmed">18310225</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood. 2004;103:4150&#x2013;6. doi: 10.1182/blood-2003-10-3685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-10-3685</ArticleId><ArticleId IdType="pubmed">14976056</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006;12:235&#x2013;9. doi: 10.1038/nm1351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1351</ArticleId><ArticleId IdType="pubmed">16462802</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SM, Mammoto T, Schultz A, et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 2006;3:e46. doi: 10.1371/journal.pmed.0030046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0030046</ArticleId><ArticleId IdType="pmc">PMC1334221</ArticleId><ArticleId IdType="pubmed">16417407</ArticleId></ArticleIdList></Reference><Reference><Citation>2008 Guidelines for diagnosis and treatment of patients infected by enteric virus EV71. [Article in Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008;20: insidebackcover.</Citation><ArticleIdList><ArticleId IdType="pubmed">18471350</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinica experts group of the ministry of health for hand, foot and mouth disease. Experts consensus on rescue and treatment of severe cases with enterovirus 71 (EV71) infection. Zhonghua Er Ke Za Zhi. 2011;49:675&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22176902</ArticleId></ArticleIdList></Reference><Reference><Citation>Fein A, Grossman RF, Jones JG, et al. The value of edema fluid protein measurement in patients with pulmonary edema. Am J Med. 1979;67:32&#x2013;8. doi: 10.1016/0002-9343(79)90066-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(79)90066-4</ArticleId><ArticleId IdType="pubmed">463915</ArticleId></ArticleIdList></Reference><Reference><Citation>Roviezzo F, Tsigkos S, Kotanidou A, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther. 2005;314:738&#x2013;44. doi: 10.1124/jpet.105.086553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.105.086553</ArticleId><ArticleId IdType="pubmed">15870388</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax. 2008;63:903&#x2013;9. doi: 10.1136/thx.2007.087387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2007.087387</ArticleId><ArticleId IdType="pubmed">18559364</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher DC, Parikh SM, Balonov K, et al. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock. 2008;29:656&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4037741</ArticleId><ArticleId IdType="pubmed">18091573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86:279&#x2013;367. doi: 10.1152/physrev.00012.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00012.2005</ArticleId><ArticleId IdType="pubmed">16371600</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabb H, Wang Z, Nemoto T, Hotchkiss J, Yokota N, Soleimani M. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int. 2003;63:600&#x2013;6. doi: 10.1046/j.1523-1755.2003.00753.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2003.00753.x</ArticleId><ArticleId IdType="pubmed">12631124</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths MJ, Ooi MH, Wong SC, et al. In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1&#x3b2;, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. J Infect Dis. 2012;206:881&#x2013;92. doi: 10.1093/infdis/jis446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis446</ArticleId><ArticleId IdType="pubmed">22829643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188:564&#x2013;70. doi: 10.1086/376998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376998</ArticleId><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis. 2003;36:269&#x2013;74. doi: 10.1086/345905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/345905</ArticleId><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>